In a paper recently published in the SLAS Discovery Journal of Biomolecular Screening, European Lead Factory (ELF) scientists from Pivot
The European Lead Factory selects first COVID-19 proposal
Over the last few months, as the world has grappled with the COVID-19 pandemic, the European Lead Factory has been
One of the sub-projects of the MMV-PDP Consortium recently received funding from the Bill and Melinda Gates Foundation, to further develop an
Novel Screening Assay for Arginase-1 Inhibitors published in SLAS Discovery
Arginase-1 is a promising new drug target for cancer immunotherapy. A novel assay technology for High-Throughput Screening (HTS) of Arginase-1
Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park – RE2423
Industrielaan 63
5349 AE Oss
The Netherlands
